FULLER & THALER ASSET MANAGEMENT, INC.
Position in AMPH — Amphastar Pharmaceuticals, Inc.
CIK 1082327
SAN MATEO, CA
Position in AMPH
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$19,155,622
-$8,175,151 QoQ
Shares Held
949,238
-32.0% QoQ
Ownership
2.23%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#8
of 209 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMPH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FULLER & THALER ASSET MANAGEMENT, INC. holds $857,277,969 across 12 Drug Manufacturers - Specialty & Generic names. AMPH ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
4,615,816 | $189,386,930 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
6,240,240 | $153,572,306 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,697 | $119,580,255 | |
| 4 | PBH |
Prestige Consumer Healthcare Inc.
|
2,331,821 | $110,225,178 | |
| 5 | LQDA |
Liquidia Corp
|
1,209,604 | $96,441,726 | |
| 6 | PRGO |
PERRIGO Co plc
|
7,498,227 | $77,906,578 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
1,632,781 | $59,106,672 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
179,149 | $30,193,772 |
All Filings in AMPH
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,155,622 | 949,238 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $27,330,773 | 1,395,139 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $37,343,719 | 1,394,463 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $36,082,154 | 1,353,927 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $29,016,205 | 1,263,772 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,631,706 | 1,263,598 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $42,065,542 | 1,132,926 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $61,185,022 | 1,260,767 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $50,912,720 | 1,272,818 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $55,949,155 | 1,274,178 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $78,736,101 | 1,273,017 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $58,647,091 | 1,275,214 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $73,532,577 | 1,279,495 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,438,525 | 811,694 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $14,011,821 | 500,065 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $20,096,586 | 715,181 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $25,275,491 | 726,516 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $22,073,294 | 614,855 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $14,240,949 | 611,462 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $7,624,911 | 401,100 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $8,052,811 | 399,445 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,290,444 | 397,950 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $10,986,977 | 546,344 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $15,328,406 | 817,515 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $18,307,797 | 815,129 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||